Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ABBV will rise by +0.07% over the next 2 Weeks and hit $189.44 by Wednesday, August 13, 2025. In that time frame, ABBV's share price is expected to range between $186.40 and $192.74.
BearishAverageBullishABBV shares rose +4.26% in Thursday, July 31, 2025's trading session, rising from a previous close of $189.39 to move at $197.45. The stock demonstrated notable intraday movement (see ABBV's key stats for a full breakdown), fluctuating between $191.77 and $198.83, a +3.68% trading range. While recent weeks have seen some volatility, ABBV has managed to secure a +3.16% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 4.96M shares changing hands, 1.38M fewer than the previous session. This amounted to $978.60M in total market activity.
Will ABBV Continue Its Downward Trend?
According to analyst ratings and projections for ABBV, AbbVie Inc. shares are anticipated to decrease by -2.45%, potentially reaching $192.74 per share by August 13, 2025. Short-term technical indicators currently suggest a neutral sentiment for ABBV. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the ABBV stock forecast, now is not the best time to buy ABBV stock because its current trading price is +4.23% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ABBV covering social and institutional perspectives.
ABBV Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ABBV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 56.90% to 62.87%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 52.76%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.82%, maintains a neutral outlook for the long term. Insights into ABBV's shareholder base show how institutional investors are positioning themselves during these momentum shifts
AbbVie Short-Term Forecasts
ABBV Forecast For Next 5 Days
Our algorithm anticipates AbbVie (ABBV) stock could hit $188.32 by Aug 07, 2025. This represents a -4.62% fall from today's price, following a -0.65% change over the past five days.
ABBV Forecast For Next 30 Days
Based on analysis of market trends, the outlook for AbbVie Inc. (ABBV) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $187.79, which would mean a -4.89% decrease from the current price of $197.45. Projections for this period range from a high of $193.47 to a low of $181.26.
ABBV Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for AbbVie's price over the next three months point to a drop. ABBV stock is expected to peak at $204.79 on Oct 31, 2025 after potentially dipping to $185.21 on Sep 15, 2025. On average, ABBV is likely to trade around $194.59 in the coming 90 days.
AbbVie Stock Forecast 2025
Based on our predictive models, AbbVie (ABBV) is expected to trade between $185.21 and $204.79 throughout 2025. This would result in an average price of $195.05, potentially offering investors a -1.22% return from current levels.
AbbVie Inc. Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, AbbVie Inc. (ABBV) is positioned to show a strong performance in July 2025. The price is predicted to move between $186.07 and $194.08, settling at an average of $190.76. This could translate to a -3.39% loss.
August 2025
Based on current market signals, AbbVie Inc. is projected to trend august 2025. We forecast a trading range from $186.66 to $200.24, with a likely average price of $192.98. Investors could expect a potential return of -2.27%.
September 2025
Our predictive algorithms indicate AbbVie Inc. stock may see a shift in September 2025. The expected range spans $185.21–$200.60, with an average target of $193.21. This represents a cautious outlook and a possible loss of -2.15%.
October 2025
Analyzing established trends, AbbVie Inc. looks set to move in October 2025. Projections place the stock between $190.44 and $204.79, averaging around $197.55. This suggests a +0.05% gain from current levels.
November 2025
Market indicators suggest AbbVie Inc. could experience notable changes during November 2025. Prices could fluctuate within $190.10 to $203.39, with a midpoint forecast of $196.24. The stock might deliver a -0.62% loss.
December 2025
Forecasting for December 2025, models estimate that AbbVie Inc. may undergo key fluctuations. If trends hold, the stock might trade between $188.88 and $203.33, averaging $195.33. This signals a cautious trajectory with potential returns around -1.08%.
January 2026
According to our latest forecast models, AbbVie Inc. (ABBV) is positioned to show a strong performance in January 2026. The price is predicted to move between $193.47 and $208.63, settling at an average of $200.95. This could translate to a +1.77% gain.
February 2026
Based on current market signals, AbbVie Inc. is projected to trend february 2026. We forecast a trading range from $192.30 to $207.78, with a likely average price of $200.18. Investors could expect a potential return of +1.38%.
March 2026
Our predictive algorithms indicate AbbVie Inc. stock may see a shift in March 2026. The expected range spans $198.51–$211.65, with an average target of $205.06. This represents a positive outlook and a possible gain of +3.85%.
April 2026
Analyzing established trends, AbbVie Inc. looks set to move in April 2026. Projections place the stock between $196.89 and $210.58, averaging around $203.53. This suggests a +3.08% gain from current levels.
May 2026
Market indicators suggest AbbVie Inc. could experience notable changes during May 2026. Prices could fluctuate within $196.67 to $209.93, with a midpoint forecast of $202.68. The stock might deliver a +2.65% gain.
June 2026
Forecasting for June 2026, models estimate that AbbVie Inc. may undergo key fluctuations. If trends hold, the stock might trade between $201.71 and $216.21, averaging $208.24. This signals a positive trajectory with potential returns around +5.46%.
July 2026
According to our latest forecast models, AbbVie Inc. (ABBV) is positioned to show a strong performance in July 2026. The price is predicted to move between $200.32 and $215.94, settling at an average of $207.91. This could translate to a +5.30% gain.
ABBV's history of dividends and stock splits also plays a role in long-term investor confidence.